Multiple human papillomavirus infection with or without type 16 and risk of cervical intraepithelial neoplasia among women with cervical cytological abnormalities.

Abstract

To evaluate the impact of multiple human papillomavirus (HPV) infections on the risk of cervical intraepithelial neoplasia grade 3 or worse (CIN3+) in subjects with cervical cytological abnormalities. A cross-sectional study of 3,842 women attending a colposcopy service was carried out. Genotyping of 18 high-risk, seven low-risk, and two undefined-risk HPVs was carried out by the INNO-LiPA genotyping system. The final colposcopic/pathological diagnoses were as follows: 1,933 (50.3%) subjects were negative; 1,041 (27.1%) CIN1; 280 (7.3%) CIN2; 520 (13.5%) CIN3; and 68 (1.8%) invasive cervical cancer. The prevalence of HPV infection was 75.8% (2,911/3,842), whereas multiple HPVs were detected in 34.5% of HPV-positive subjects (2,255/3,842). The adjusted risks of CIN3+ in the group with multiple compared to the group with single infection were 2.31 (95% CI=1.54-3.47), among HPV16-positive women, and 3.25 (95% CI=2.29-4.61, p=0.21 compared with HPV16-positive subjects), in HPV16-negative subjects. Out of a total of 1,285 subjects with mild lesions, followed up for a median of 16.1months (interquartile range=8.9-36.8), the rate of progression to CIN2-3 was 0.6% (5/541) among subjects negative or with low-risk HPVs, 1.7% (8/463) among those with single high-risk HPV, and 5% (14/281, p<0.001 compared with HPV-negative/low-risk HPV and p=0.038 compared with single high-risk HPV) among those with multiple high-risk HPVs. Among women with cervical cytological abnormalities, infection by multiple high-risk HPVs increased the risk of CIN3+ in both HPV16-positive and HPV16-negative subjects. These findings suggest a potential synergistic interaction between high-risk HPVs, favoring the progression of CIN lesions.